NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
Cancer cells respond differently to inhibitors of Poly (ADP-ribose) polymerase. Here the authors reveal that ovarian cancer cells with higher cellular NADP+ levels are more sensitive to clinically relevant PARP1 inhibitors and show that NADP+ act as an endogenous inhibitor of PARP enzymes.
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5bbffa525898454999e7e01354382c95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5bbffa525898454999e7e01354382c95 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5bbffa525898454999e7e01354382c952021-12-02T16:57:41ZNADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression10.1038/s41467-019-08530-52041-1723https://doaj.org/article/5bbffa525898454999e7e01354382c952019-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-08530-5https://doaj.org/toc/2041-1723Cancer cells respond differently to inhibitors of Poly (ADP-ribose) polymerase. Here the authors reveal that ovarian cancer cells with higher cellular NADP+ levels are more sensitive to clinically relevant PARP1 inhibitors and show that NADP+ act as an endogenous inhibitor of PARP enzymes.Chunjing BianChao ZhangTao LuoAditi VyasShih-Hsun ChenChao LiuMuzaffer Ahmad KassabYing YangMei KongXiaochun YuNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-14 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Chunjing Bian Chao Zhang Tao Luo Aditi Vyas Shih-Hsun Chen Chao Liu Muzaffer Ahmad Kassab Ying Yang Mei Kong Xiaochun Yu NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression |
description |
Cancer cells respond differently to inhibitors of Poly (ADP-ribose) polymerase. Here the authors reveal that ovarian cancer cells with higher cellular NADP+ levels are more sensitive to clinically relevant PARP1 inhibitors and show that NADP+ act as an endogenous inhibitor of PARP enzymes. |
format |
article |
author |
Chunjing Bian Chao Zhang Tao Luo Aditi Vyas Shih-Hsun Chen Chao Liu Muzaffer Ahmad Kassab Ying Yang Mei Kong Xiaochun Yu |
author_facet |
Chunjing Bian Chao Zhang Tao Luo Aditi Vyas Shih-Hsun Chen Chao Liu Muzaffer Ahmad Kassab Ying Yang Mei Kong Xiaochun Yu |
author_sort |
Chunjing Bian |
title |
NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression |
title_short |
NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression |
title_full |
NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression |
title_fullStr |
NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression |
title_full_unstemmed |
NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression |
title_sort |
nadp+ is an endogenous parp inhibitor in dna damage response and tumor suppression |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/5bbffa525898454999e7e01354382c95 |
work_keys_str_mv |
AT chunjingbian nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression AT chaozhang nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression AT taoluo nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression AT aditivyas nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression AT shihhsunchen nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression AT chaoliu nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression AT muzafferahmadkassab nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression AT yingyang nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression AT meikong nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression AT xiaochunyu nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression |
_version_ |
1718382502550175744 |